Details of Data Requests to Use Johnson and Johnson Data

Request listing updated daily

All Requests

The YODA Project posts proposals once data access has been granted or denied.

Approved Requests

The YODA Project posts approved proposals once data access has been granted.

Withdrawn Requests

The following data requests could not be fulfilled due to patient privacy concerns, data element availability, data security concerns, or lack of research proposal clarity. The YODA Project posts withdrawn/unapproved proposals at the time the decision is made.

Filters list

YODA Protocol Number 2022-4961
Product(s) of Interest REMICADE® (Infliximab) SIMPONI® (Golimumab)
No. Trials Provided 3
Ongoing

Efficacy and safety of tumor necrosis factor inhibitors (TNFi) in seronegative rheumatoid arthritis patients who are inadequate responders to csDMARDs

Principal Investigator

Carl Turesson Clinical Sciences Malmö, Lund University, Malmö

Protocol & Associated Materials

Protocol #2022-4961 Proposal (PDF) Protocol #2022-4961 Review (PDF) Protocol #2022-4961 Due Diligence Assessment (PDF)
of